Early stages of probable Alzheimer disease are associated with changes in platelet amyloid precursor protein forms

Neurological Sciences

Volumn 23, Issue 5, 2002, Pages 207-210

  Borroni, B ^a   Colciaghi, F ^b   Corsini, P ^a   Akkawi, N ^a   Rozzini, L ^a   Del Zotto, E ^a   Talarico, G ^c   Cattabeni, F ^b   Lenzi, G L ^c   Di Luca, M ^b   Padovani, A ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Amyloid precursor protein; Diagnosis; Early stage Alzheimer disease; Platelets

Indexed keywords

AMYLOID PRECURSOR PROTEIN; BIOLOGICAL MARKER;

AGED; AGING; ALZHEIMER DISEASE; ARTICLE; CELL LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE MARKER; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN CELL; MALE; PROTEIN PROCESSING; RATING SCALE; STAGING; THROMBOCYTE;

AGED; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; BIOLOGICAL MARKERS; BLOOD PLATELETS; FEMALE; HUMANS; MALE; MATCHED-PAIR ANALYSIS; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 0036914698     PISSN: 15901874     EISSN: None     Source Type: Journal    
DOI: 10.1007/s100720200042     Document Type: Article

References (28)

1. McKhann G, Drachman D, Folstein M (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 34:939-944
2. Klatka LA, Schiffer RB, Powers JM (1996) Incorrect diagnosis of Alzheimer disease: a clinicopathologic study. Arch Neurol 53:35-42
3. Mendez M, Mastri AR, Sung JH (1992) Clinically diagnosed Alzheimer disease: neuropathologic findings in 650 cases. Alzheimer Dis Assoc Disord 6:35-43
4. Small GW, Rabins PV, Barry PP (1997) Diagnosis and treatment of Alzheimer disease and related disorders: consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association, and the American Geriatrics Society. JAMA 278:1363-1371
5. Bush AI, Martins RN, Rumble B (1990) The amyloid precursor protein of Alzheimer's disease is released by human platelets. J Biol Chem 265:15977-15983
6. Davies TA, Long HJ, Sgro, K (1997) Activated Alzheimer disease platelets retain more beta amyloid precursor protein. Neurobiol Aging 18:147-153
7. Li QX, White S, Tanner J (1998) Secretion of Alzheimer disease A β amyloid peptide by activation of human platelets. Lab Invest 78:461-469
8. Selkoe DJ, Podlisny MB, Joachim CL (1988) Beta-amyloid precursor protein of Alzheimer disease occurs as 110- to 135-kilodalton membrane-associated proteins in neural and non-neural tissues. Proc Natl Acad Sci U S A 85:7341-7345
9. Di Luca M, Pastorino L, Cattabeni F (1996) Abnormal pattern of platelet APP isoforms in Alzheimer disease and Down syndrome. Arch Neurol 53:1162-1166
10. Rosenberg RN, Baskin F, Fosmire JA (1997) Altered amyloid protein processing in platelets of patients with Alzheimer disease. Arch Neurol 54:139-144
11. Di Luca M, Pastorino L, Bianchetti A (1998) Differential pattern of platelet APP isoforms: an early marker for Alzheimer disease. Arch Neurol 55:1195-1200
12. Baskin F, Rosenberg RN, Iyer L (2000) Platelet APP isoform ratios correlate with declining cognition in AD. Neurology 54:1907-1909
13. Padovani A, Pastorino L, Borroni B (2002) Amyloid precursor protein in platelets: a peripheral marker for the diagnosis of sporadic AD. Neurology (in press)
14. American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders, 4 edn. Washington, DC
15. McKhann G, Drachman D, Folstein M (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 34:939-944
16. Burke WJ, Miller JP, Rubin EH (1998) Reliability of the Washington University of clinical dementia rating. Arch Neurol 45:31-32
17. Folstein MF, Folstein SE, McHugh PR (1975) "Mini-Mental State": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189-198
18. Padovani A, Borroni B, Colciaghi F (2002) Platelet amyloid precursor protein forms in AD: a peripheral diagnostic tool and a pharmacological target. Mech Ageing Dev (in press)
19. Di Luca M, Colciaghi F, Pastorino L (2000) Platelets as a peripheral district where to study pathogenetic mechanism of Alzheimer disease: the case of amyloid precursor protein. Eur J Pharmacol 405:277-284
20. Sevush S, Horstman LL, Mao WW (1998) Platelet activation in Alzheimer disease. Arch Neurol 55:530-536
21. Bush AI, Tanzi RE (1998) Alzheimer disease-related abnormalities of amyloid beta precursor protein isoforms in the platelets - the brain delegates in the periphery. Arch Neurol 55:1179-1180
22. Zubenko GS (1993) Platelet membrane fluidity. Neurology 43:234-236
23. Matsushima H, Shimohama S, Fujimoto S (1995) Changes in platelet phospholipase C protein level and activity in Alzheimer's disease. Neurobiol Aging 16:895-900
24. Matsushima H, Shimohama S, Tanaka S (1994) Platelet protein kinase C levels in Alzheimer's disease. Neurobiol Aging 15:671-674
25. Mehta PD, Pirttila T, Mehta SP (2000) Plasma and cerebrospinal fluid levels of amyloid β proteins 1-40 and 1-42 in Alzheimer disease. Arch Neurol 57:100-105
26. Riemenschneidr M, Buch K, Schmolke M (1996) Cerebrospinal protein tau is elevated in early Alzheimer's disease. Neurosci Lett 212:209-211
27. Andreasen N, Hesse C, Davidsson P (1999) Cerebrospinal fluid β-amyloid (1-42) in Alzheimer disease. Difference between early and late-onset Alzheimer disease and stability during the course of disease. Arch Neurol 56:673-680
28. Hulstaert F, Blennow K, Ivanoiu A (1999) Improved discrimination of AD patients using β-amyloid(1-42) and tau levels in CSF. Neurology 52:1555-1564